Peter Martin Hjørnet Kamper

5PUBLICATIONS

20CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 30, 2026

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

|Apr 01, 2026

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Ninja Övergaard, Kjersti Lia, Jeremia Collin

|Jan 21, 2026

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Sophie-Charlott Seidenfaden, Thomas Graversgaard Adams, Peter Kamper

|Dec 03, 2024

Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.

Maja Dam Andersen, Katharina Wolter, Marie Hairing Enemark

|Oct 26, 2018

Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.

Jonas Juul Hansen, Hans Beier Ommen, Lars Christian Gormsen

Pageof 1

Frequent Collaborators

Daniel Molin

Maja Dam Andersen

Katharina Wolter

Marie Hairing Enemark

1 joint publications

Kristina Lystlund Lauridsen

1 joint publications

Maja Ludvigsen

1 joint publications

Bent Honoré

1 joint publications

Thomas Graversgaard Adams

1 joint publications

Martin Bjerregård Pedersen

1 joint publications

Ninja Övergaard

Frequent Collaborators

Daniel Molin

Maja Dam Andersen

Katharina Wolter

Marie Hairing Enemark